BlackRock, Inc. (NYSE: BLK) announced today that its iShares business
led the global industry by capturing $102.8bn in new flows in 2014, 31%
of the record-breaking $330.7bn global exchange traded fund (ETF) market
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin Data published in New England Journal of Medicine and featured at the American Society of Hematology annual meeting
Isis to host a webcast at 9:00 a.m. ET on Monday, December 8, 2014 CARLSBAD, Calif.
Isis Pharmacueticals Inc. (ISIS) said Thursday it expects to "significantly" improve on its 2014 guidance, ending the year with a pro forma net operating loss in the mid to high teens and more than $725 million cash.
- Isis Outperforms 2014 Projections for Pro Forma Net Operating Loss and Year-end Cash - Isis Achieves Profitable Fourth Quarter - More than $230 Million in Payments from Partners Drives Significantly Improved Financial Results
- Conference Call Webcast Friday, February 27, 10:30 a.m. ET at www.isispharm.com CARLSBAD, Calif.
Terence Bernard Wise, the largest shareholder and member of the board of
directors of Forward Industries, Inc. (NASDAQ: FORD), is pleased to
announce that ISS, the world’s leading provider of corporate governance
solutions, recommends Forward Industries shareholders vote on the GOLD
proxy card for Mr.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.